Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Ther
Fiche publication
Date publication
mai 2022
Journal
Journal of cancer research and clinical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERCEANU Ana, Dr POCHON Cécile
Tous les auteurs :
Grain A, Rialland-Battisti F, Chevallier P, Blin N, Dalle JH, Michel G, Dhédin N, Peffault de Latour R, Pochon C, Yakoub-Agha I, Bertrand Y, Sirvent A, Jubert C, Forcade E, Berceanu A, Gandemer V, Schneider P, Bay JO, Rohrlich PS, Brissot E, Paillard C, Plantaz D, Nguyen Quoc S, Gonzales F, Maillard N, Planche L, Baruchel A
Lien Pubmed
Résumé
In the acute lymphoblastic leukemia (ALL) landscape, adolescents and young adults (AYA) often present high-risk diseases and increased chemotherapy-related toxicity. Studies analyzing the outcomes of AYA after hematopoietic stem cell transplantation (HSCT) are scarce. Our study aimed to compare the outcomes of children and AYA with ALL after HSCT and to determine the factors influencing potential differences.
Mots clés
Acute lymphoblastic leukemia, Adolescents and young adults, Graft versus host disease, Hematopoietic stem cell transplantation
Référence
J Cancer Res Clin Oncol. 2022 May 4;: